We are looking for a Scientific Manager Functional Characterization & Bioassays to strengthen our team of bioassay specialists. This role within the Functional Characterization and Bioassays (FCB) team is part of CMC Science and Technologies and develops bioassays to demonstrate the quality and characteristics of Genmab’s antibody products.

As Scientific Manager Functional Characterization & Bioassays you will be responsible for managing a team of up to five research associates dedicated to developing and validating (mostly) cell-based assays. Specifically, you will design and develop assays for selected clinical candidates in the preclinical and early clinical stage of development. In addition, you will participate in cross-functional product characterization studies to support regulatory filing.

You recognize yourself as an empathetic people manager who cares for the wellbeing and personal development of your team members. With your solid bioassay knowledge and excellent communication skills, you represent the CMC bioassay expertise within our organization. The position will report to the Director, Functional Characterization and Bioassays lead.

Responsibilities

• Managerial/supervisory responsibilities.
• Subject matter expert on cell-based potency assays, such as viability assays, reporter gene assays and primary cell-based assays.
• Scientific oversight of assay development and structure-function studies.
• Act as an author/reviewer of necessary documentation.
• Collaborating with internal and external stakeholders.
• Planning and prioritization of activities within sub team.
• Keeping the team up to date with the latest developments in the field, such as novel technologies and regulatory requirements.

Requirements

• A PhD in a relevant life science field or MSc with several years of relevant experience.
• Approximately two years of experience in a people management role, preferably in an industry setting.
• Experience with developing and troubleshooting of cell-based assays (e.g. luminescence assays, flow cytometry, Incucyte). Experience with statistics (JMP) and developing assays according to aQbD principles would be advantageous.
• Ability to run several projects parallel to each other and adjust priorities appropriately with the team.
• Affinity for introducing automated solutions for assay development.
• Excellent relational and communication skills in English. Previous experience of managing external collaborations is beneficial.
• Motivated by creating an inclusive and collaborative work environment.

About You

• You are passionate about our purpose and genuinely care about our mission to transform the lives of patients through innovative cancer treatment
• You bring rigor and excellence to all that you do. You are a fierce believer in our rooted-in-science approach to problem-solving
• You are a generous collaborator who can work in teams with diverse backgrounds
• You are determined to do and be your best and take pride in enabling the best work of others on the team
• You are not afraid to grapple with the unknown and be innovative
• You have experience working in a fast-growing, dynamic company (or a strong desire to)
• You work hard and are not afraid to have a little fun while you do so

Locations

Genmab leverages the effectiveness of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are designed as open, community-based spaces that work to connect employees while being immersed in our state-of-the-art laboratories. Whether you’re in one of our collaboratively designed office spaces or working remotely, we thrive on connecting with each other to innovate.

About Genmab

Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For more than 20 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO™) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan.